The world's first 2019-nCoV CLIA Kits received CE mark

Release Date:2020-03-06

Shenzhen, 19 February 2020 - Snibe announced that MAGLUMI 2019-nCoV (official name SARS-CoV-2) IgM/IgG Kits have got CE marked and are available to come into service.


Having passed rigorous clinical verification in China, MAGLUMI 2019-nCoV IgM/IgG Kits is proven to possess great performance. With the advantage of rapid detection and high specificity, the new 2019-nCoV lgG/lgM kits can be tremendously helpful for early diagnosis of SARS-CoV-2 infection and e reducing the false-negative case of 2019-nCoV nucleic acid assay, which can greatly improve the diagnosis of SARS-CoV-2 virus in labs and hospitals.


With the increased number of COVID-19 cases outbreaks around the world, in order to improve the clinical diagnosis speed and reduce widespread of SARS-CoV-2, the first batch of MAGLUMI 2019-nCoV reagent kits have been distributed to several key hospitals in China, Italy and other countries with severe epidemics for cooperation in the past weeks.


Snibe is always concerned about global public health and security and ready to help governments cope with public health emergencies. We believe with all the efforts from the society, we will get the victory in the fight against the SARS-CoV-2 very soon.

Advantage & Benefit

● The World's First CE Marked CLIA Antibody Assay for COVID-19
● Inactivated Serum/Plasma samples(56℃, 30mins) applicable to ensure operator's safety
World's Fastest Fully automated CLIA solution (High throughput and sensitivity method)
● Antibody detection with numerical result using ONLY 10μL sample volume 
● Assist early detection of 2019-nCoV suspicious cases with nucleic acid false negative
Joint Detection Solution (IgG+IgM)for SARS-CoV-2 to ensure high clinical sensitivity
● Rapid detection within 30 mins (Analyzer model dependent)
The First COVID-19 Antibody Reagents Supplier with Major Lab Automation connectability (Thermo Scientific/Inpeco Track)
High production capacity with advanced automatic production line